title: Cutaneous adverse drug reactions notified by pharmacovigilance in a tertiary care hospital in north India.
abstract: BACKGROUND
  Medication-related adverse events, apart from causing significant morbidity and mortality, increase the healthcare cost burden and lead to early treatment discontinuations.
  
  
  OBJECTIVE
  Knowing the fact that cutaneous adverse drug reactions (cADRs) are most frequent, this study was conducted with an aim to describe their clinical profiles and preventive strategies.
  
  
  METHODS
  All adverse drug reaction (ADR) forms filled from January 2012 to January 2013 were scrutinised and forms with cADRs analysed and assessed for causality, preventability and severity.
  
  
  RESULTS
  Of 400 ADR forms, 109 included cADRs. Sixty-eight percent patients were males and mean ± SD age was 35 ± 18 years. Rash, Steven-Johnson syndrome and toxic epidermal necrolysis were the most common presentations. Most frequent culprit drugs included antibiotics and anti-inflammatory agents. Causality was probable or possible in majority. Ninety percent cases were "not preventable". Majority of the patients had mild to moderate reactions and recovered completely after medical management.
  
  
  CONCLUSIONS
  Pharmacovigilance, with special attention to monitoring and reporting of cADRs must be encouraged. As major bulk of cADRs result from physician prescribed drugs, awareness on part of the physician can help in their timely detection and management, thereby restricting the associated damage.
authors: Postgraduate Institute of Medical Sciences , Rohtak, Haryana , India.
authors: Niti
authors: N
authors: Mittal
authors: Mahesh
authors: M
authors: Gupta
authors: Mohit
authors: M
authors: Singla
mesh_terms: D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000368:Aged; D000369:Aged, 80 and over; D002648:Child; D002675:Child, Preschool; D003875:Drug Eruptions / Q000453:epidemiology / Q000473:pathology / Q000628:therapy; D064420:Drug-Related Side Effects and Adverse Reactions; D005260:Female; D006801:Humans; D007194:India / Q000453:epidemiology; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D008875:Middle Aged; D060735:Pharmacovigilance; D015995:Prevalence; D012307:Risk Factors; D012737:Sex Factors; D012867:Skin / Q000473:pathology; D062606:Tertiary Care Centers; D016896:Treatment Outcome; D055815:Young Adult
keywords: Adverse reactions; causality; cutaneous; pharmacovigilance; preventability